{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:42:14Z","timestamp":1793072534629,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.atherosclerosis.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T23:30:08Z","timestamp":1460676608000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease"],"prefix":"10.1016","volume":"249","author":[{"given":"P","family":"Maga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Rewerska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Maga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jawien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wachsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Rewerski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Celejewska-W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib2","series-title":"Five-lipoxygenase Products in Asthma","first-page":"1","article-title":"Overview of the 5-lipoxygenase pathway","author":"Haeggstrom","year":"1998"},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib3","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.76.7.3213","article-title":"Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids","volume":"76","author":"Borgeat","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMp038190","article-title":"From asthma to atherosclerosis \u2013 5-lipoxygenase, leukotrienes, and inflammation","volume":"350","author":"De Caterina","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI5897","article-title":"Disruption of the 12\/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice","volume":"103","author":"Cyrus","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.RES.0000028008.99774.7F","article-title":"Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice","volume":"91","author":"Mehrabian","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib7","first-page":"S182","article-title":"Leukotriene B4 production in human atherosclerotic plaques","volume":"47","author":"De Caterina","year":"1988","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.ATV.0000082460.58448.01","article-title":"5-lipoxygenase\u2013derived leukotrienes. Mediators also of atherosclerotic inflammation","volume":"23","author":"Radmark","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1358\/dnp.2003.16.8.829345","article-title":"The potential role of antileukotriene drugs in atherosclerosis","volume":"16","author":"Spanbroek","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/hq0302.105593","article-title":"Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice","volume":"22","author":"Aiello","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib11","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/01.ATV.0000082690.23131.CB","article-title":"Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis","volume":"23","author":"Lotzer","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2362.2006.01606.x","article-title":"Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE\/LDLR double knockout mice","volume":"36","author":"Jawie\u0144","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib13","article-title":"BAYx1005 attenuates atherosclerosis in apoE\/LDLR \u2013 double knockout mice","volume":"58","author":"Jawie\u0144","year":"2007","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib14","first-page":"633","article-title":"The effect of montelukast on atherogenesis in apoE\/LDLR \u2013 double knockout mice","volume":"59","author":"Jawie\u0144","year":"2008","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.iac.2007.09.004","article-title":"Urinary leukotriene E4","volume":"27","author":"Rabinovitch","year":"2007","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s002100100398","article-title":"Effect of smoking cessation and nicotine substitution on systemic eicosanoid production in man","volume":"363","author":"Saareks","year":"2001","journal-title":"Naunyn Schmeideb. Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.04.013_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0735-1097(91)90842-W","article-title":"Transcardiac release of leukotriene C4 by neutrophils in patients with coronary artery disease","volume":"17","author":"De Servi","year":"1991","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2016.04.013_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00019501-199310000-00009","article-title":"Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery","volume":"4","author":"Allen","year":"1993","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib19","first-page":"705","article-title":"Leukotrienes biosynthesis in vascular surgery patients during perioperative period","volume":"65","author":"Szczeklik","year":"2014","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib20","first-page":"22","article-title":"Reference urinary LTE4 levels in normal individuals: a pilot study","volume":"43","author":"Dal Negro","year":"2011","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.avsg.2015.08.016","article-title":"Costs of real-life endovascular treatment of critical limb ischemia: report from Poland-a European Union Country with a low-budget health care system","volume":"31","author":"Krzanowski","year":"2016","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvq016","article-title":"The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease","volume":"86","author":"Poeckel","year":"2010","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10557-008-6140-9","article-title":"Leukotriene signaling in atherosclerosis and ischemia","volume":"23","author":"B\u00e4ck","year":"2009","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng1311","article-title":"The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke","volume":"36","author":"Helgadottir","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa025079","article-title":"Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis","volume":"350","author":"Dwyer","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng1692","article-title":"A\u00a0variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction","volume":"38","author":"Helgadottir","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","article-title":"The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm","volume":"10","author":"Zhao","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib28","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1073\/pnas.242716099","article-title":"Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis","volume":"100","author":"Spanbroek","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib29","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0602414103","article-title":"Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability","volume":"103","author":"Qiu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib30","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1096\/fj.08-116202","article-title":"Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus","volume":"23","author":"Houard","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib31","doi-asserted-by":"crossref","first-page":"21093","DOI":"10.1073\/pnas.1015166107","article-title":"Increased expression of leukotriene C 4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm","volume":"107","author":"Di Gennaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-5347(25)00223-X","article-title":"Leukotriene biosynthesis by canine and human coronary arteries","volume":"241","author":"Piomelli","year":"1987","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.CIR.86.1.56","article-title":"Angioplasty triggers intracoronary leukotrienes and lipoxin A4: impact of aspirin therapy","volume":"86","author":"Brezinski","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1183\/09031936.00137107","article-title":"Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?","volume":"32","author":"Lefebvre","year":"2008","journal-title":"Eur. Resp. J."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaci.2009.05.033","article-title":"Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia","volume":"124","author":"Stanke-Labesque","year":"2009","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib36","doi-asserted-by":"crossref","first-page":"e1351","DOI":"10.1371\/journal.pone.0001351","article-title":"The oral cavity and age: a site of chronic inflammation?","volume":"2","author":"Back","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.atherosclerosis.2006.07.003","article-title":"Increased leukotriene concentrations in gingival crevicular fluid from subjects with periodontal disease and atherosclerosis","volume":"193","author":"Back","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2015.05.007","article-title":"The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE-\/- mice","author":"Ketelhuth","year":"2015","journal-title":"Prostagl. Other Lipid Mediat"},{"key":"10.1016\/j.atherosclerosis.2016.04.013_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10753-011-9294-8","article-title":"Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients","volume":"35","author":"Pillai","year":"2012","journal-title":"Inflammation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016301447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016301447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T18:50:04Z","timestamp":1748890204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016301447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":39,"alternative-id":["S0021915016301447"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.04.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}